Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FH-006 in Advanced Malignant Solid Tumors
NCT07136142Phase 2Recruiting
- Sponsor
- Hengrui
- Start
- Sep 2025
- Primary completion
- Feb 2027
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of FH-006 in malignant solid tumor, sponsored by Hengrui. Started Sep 2025; status: recruiting.
02
Drugs
FH-006
03
Conditions
malignant solid tumor
Beyond the preview
Go deeper on NCT07136142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07136142.